» Authors » A N Sun

A N Sun

Explore the profile of A N Sun including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 176
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu X, Yang Z, Lu C, Zhang X, Sun A, Zhou H, et al.
Zhonghua Xue Ye Xue Za Zhi . 2025 Jan; 45(11):1051-1054. PMID: 39746700
Acute leukemia of ambiguous lineage (ALAL) is a rare type of acute leukemia and is extremely difficult to treat. Here, we present six patients with CD19-positive ALAL who were successfully...
2.
Wang Z, Li L, Xue S, Zhu Z, Xu J, Lu T, et al.
Zhonghua Xue Ye Xue Za Zhi . 2025 Jan; 45(11):1005-1009. PMID: 39746693
This study aimed to analyze cytomegalovirus (CMV) reactivation and its influencing factors in patients with B-lymphocyte malignancy who received chimeric antigen receptor T (CAR-T) cell therapy. This study retrospectively reviewed...
3.
Zhou M, Kang H, Gu C, Liu Y, Wang Y, Miao M, et al.
Zhonghua Xue Ye Xue Za Zhi . 2023 Aug; 44(6):484-489. PMID: 37550204
To assess the efficacy and safety of polymyxin B in neutropenic patients with hematologic disorders who had refractory gram-negative bacterial bloodstream infection. From August 2021 to July 2022, we retrospectively...
4.
Kong X, Zhang J, Li M, Sun A, Han Y, Tang X, et al.
Zhonghua Xue Ye Xue Za Zhi . 2023 Jan; 43(12):1038-1042. PMID: 36709111
No abstract available.
5.
Zheng X, Liang A, Yang X, Fu J, Hou M, Sun A, et al.
Zhonghua Xue Ye Xue Za Zhi . 2021 Jan; 41(12):1031-1034. PMID: 33445852
No abstract available.
6.
Wu Y, Wu D, Chen S, Qiu H, Han Y, Li C, et al.
Zhonghua Xue Ye Xue Za Zhi . 2021 Jan; 41(12):1025-1030. PMID: 33445851
To summarize the clinical characteristics of an early death in patients with de novo acute promyelocytic leukemia (APL) , analyze the risk factors and direct causes of early death, and...
7.
Yan M, Wu Y, Chen F, Tang X, Han Y, Qiu H, et al.
Zhonghua Xue Ye Xue Za Zhi . 2020 Oct; 41(9):710-715. PMID: 33113601
This study aims to investigate the efficacy and safety of chimeric antigen receptor (CAR) T-cell bridging allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of recurrent and refractory acute...
8.
Liu L, Zhou H, Wang Q, Qiu H, Tang X, Han Y, et al.
Zhonghua Xue Ye Xue Za Zhi . 2019 Jul; 40(6):472-476. PMID: 31340619
To compare the outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for paroxysmal nocturnal hemoglobinuria (PNH) with paroxysmal nocturnal hemoglobinuria-aplastic anemia (PNH-AA) syndrome. The outcomes of 46 patients who received...
9.
Liu L, Zhou H, Wang Q, Qiu H, Tang X, Han Y, et al.
Zhonghua Xue Ye Xue Za Zhi . 2019 May; 40(4):306-311. PMID: 31104442
To compare the outcomes between haploidentical donor hematopoietic stem cell transplantation (haplo-HSCT) and matched-sibling donor transplantation (MSD-HSCT) for paroxysmal nocturnal hemoglobinuria (PNH) . The clinical data of 40 PNH patients...
10.
Yan L, Chen S, He X, Zhao Y, Zhang X, Wu L, et al.
Zhonghua Xue Ye Xue Za Zhi . 2018 Sep; 39(8):682-685. PMID: 30180473
No abstract available.